• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物在治疗肠易激综合征中的潜力。

Potential of natural products in the treatment of irritable bowel syndrome.

机构信息

Department of Pharmaceutical Sciences, Zunyi Medical University, Zhuhai Campus, Zhuhai 519041, PR China.

College of Pharmacy, Zunyi Medical University, Zunyi 563000, PR China.

出版信息

Phytomedicine. 2022 Nov;106:154419. doi: 10.1016/j.phymed.2022.154419. Epub 2022 Aug 27.

DOI:10.1016/j.phymed.2022.154419
PMID:36087525
Abstract

BACKGROUND

Irritable bowel syndrome (IBS) is a kind of functional bowel disease that is characterized by bellyache, abdominal distension, and diarrhea. Although not life-threatening, IBS has a long course and recurrent attacks and seriously affects the life quality of patients. Current drugs for treating IBS possess remarkable limitations, such as limited efficacy and severe adverse reactions. Therefore, developing novel medications to treat IBS is quite essential, and natural products may be a substantial source.

PURPOSE

This is the first systematic review elaborating the recent advancement of natural products as potential drugs for the therapy of IBS.

METHODS

A comprehensive retrieval of studies was carried out in scientific databases including PubMed, Web of Science, Elsevier, and CNKI. By using ("irritable bowel syndrome" OR "IBS") AND ("natural product" OR "natural compound" OR "phytochemical") as keywords, the eligible studies were screened, and the relevant information about therapeutic action and mechanism of natural products treating IBS was extracted.

RESULTS

Natural products against IBS consisted of four categories, namely, terpenoids, flavonoids, alkaloids, and phenols. Furthermore, the underlying mechanisms for natural products treating IBS were tightly associated with increased TJs and mucus protein expression, regulation of the brain-gut axis and gut microbiota structure, and inhibition of inflammatory response and intestinal mucosal damage.

CONCLUSION

Natural products could be extremely prospective candidate drugs used to treat IBS, and further preclinical and clinical researches are needed to guarantee their efficacy and safety.

摘要

背景

肠易激综合征(IBS)是一种功能性肠病,其特征为腹痛、腹胀和腹泻。尽管不会危及生命,但 IBS 病程长且反复发作,严重影响患者的生活质量。目前治疗 IBS 的药物存在疗效有限和严重不良反应等显著局限性。因此,开发治疗 IBS 的新型药物非常必要,而天然产物可能是一个重要的来源。

目的

这是第一篇系统综述,详细阐述了天然产物作为治疗 IBS 潜在药物的最新进展。

方法

在包括 PubMed、Web of Science、Elsevier 和中国知网在内的科学数据库中进行了全面检索。使用“irritable bowel syndrome”或“IBS”和“natural product”或“natural compound”或“phytochemical”作为关键词,筛选合格的研究,并提取关于天然产物治疗 IBS 的治疗作用和机制的相关信息。

结果

治疗 IBS 的天然产物包括萜类化合物、黄酮类化合物、生物碱和酚类化合物四大类。此外,天然产物治疗 IBS 的潜在机制与增加 TJ 和粘蛋白表达、调节脑-肠轴和肠道微生物结构以及抑制炎症反应和肠道黏膜损伤密切相关。

结论

天然产物可能是治疗 IBS 的极有前景的候选药物,需要进一步的临床前和临床研究来保证其疗效和安全性。

相似文献

1
Potential of natural products in the treatment of irritable bowel syndrome.天然产物在治疗肠易激综合征中的潜力。
Phytomedicine. 2022 Nov;106:154419. doi: 10.1016/j.phymed.2022.154419. Epub 2022 Aug 27.
2
[Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].[肠易激综合征、情绪调节与肠道微生物群]
Brain Nerve. 2016 Jun;68(6):607-15. doi: 10.11477/mf.1416200448.
3
Recent advances in pharmacological treatment of irritable bowel syndrome.肠易激综合征药物治疗的最新进展
World J Gastroenterol. 2014 Jul 21;20(27):8867-85. doi: 10.3748/wjg.v20.i27.8867.
4
Vitamin D Supplementation and Mental Health in Inflammatory Bowel Diseases and Irritable Bowel Syndrome Patients: A Systematic Review.维生素 D 补充与炎症性肠病和肠易激综合征患者的心理健康:系统评价。
Nutrients. 2021 Oct 19;13(10):3662. doi: 10.3390/nu13103662.
5
Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives.关于 Eluxadoline 治疗腹泻型肠易激综合征的最新进展:患者选择和观点。
Drug Des Devel Ther. 2020 Apr 9;14:1391-1400. doi: 10.2147/DDDT.S216056. eCollection 2020.
6
Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.综述文章:肠道微生物群在肠易激综合征中的作用及其对治疗靶点的潜在影响的证据。
Aliment Pharmacol Ther. 2014 May;39(10):1033-42. doi: 10.1111/apt.12728. Epub 2014 Mar 25.
7
Treatment of irritable bowel syndrome.肠易激综合征的治疗。
J Clin Pharm Ther. 2011 Jun;36(3):275-82. doi: 10.1111/j.1365-2710.2010.01177.x. Epub 2010 Aug 24.
8
Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.肠道微生物群的调节:聚焦于肠易激综合征的治疗
Postgrad Med. 2017 Nov;129(8):872-888. doi: 10.1080/00325481.2017.1383819. Epub 2017 Oct 13.
9
Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.腹泻型肠易激综合征管理的最新进展:聚焦利福昔明和埃索美拉嗪。 (注:原文中Eluxadoline应为Eluxadroline,中文通用名是埃索美拉嗪,是一种治疗腹泻型肠易激综合征的药物。这里按照正确名称翻译了,原译文可能存在拼写错误。)
Pharmacotherapy. 2016 Mar;36(3):300-16. doi: 10.1002/phar.1712. Epub 2016 Mar 11.
10
Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.综述:利福昔明治疗腹泻型肠易激综合征的潜在作用机制。
Aliment Pharmacol Ther. 2016 Jan;43 Suppl 1:37-49. doi: 10.1111/apt.13437.

引用本文的文献

1
Unlocking the Therapeutic Potential of Patchouli Leaves: A Comprehensive Review of Phytochemical and Pharmacological Insights.解锁广藿香叶的治疗潜力:植物化学与药理学见解的全面综述
Plants (Basel). 2025 Mar 26;14(7):1034. doi: 10.3390/plants14071034.
2
The PDIA3-STAT3 protein complex regulates IBS formation and development via CTSS/MHC-II pathway-mediated intestinal inflammation.PDIA3-STAT3蛋白复合物通过CTSS/MHC-II途径介导的肠道炎症调节肠易激综合征的形成和发展。
Heliyon. 2024 Aug 28;10(17):e36357. doi: 10.1016/j.heliyon.2024.e36357. eCollection 2024 Sep 15.
3
ZO-1 and IL-1RAP Phosphorylation: Potential Role in Mediated Brain-Gut Axis Dysregulation in Irritable Bowel Syndrome-like Stressed Mice.
ZO-1 和 IL-1RAP 磷酸化:在应激诱导的似肠易激综合征小鼠的脑-肠轴失调中的潜在作用。
Int J Med Sci. 2024 Jul 2;21(9):1738-1755. doi: 10.7150/ijms.95848. eCollection 2024.
4
Glycosides as Potential Medicinal Components for Ulcerative Colitis: A Review.糖苷类化合物作为溃疡性结肠炎潜在药用成分的研究进展。
Molecules. 2023 Jul 4;28(13):5210. doi: 10.3390/molecules28135210.
5
, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases., 一种具有数百年历史的药用真菌:在胃肠道疾病中的证据。
World J Gastroenterol. 2023 May 28;29(20):3048-3065. doi: 10.3748/wjg.v29.i20.3048.